Breathe Well Live Well
|
Asthma inhaler lodged in chest highlights importance of warning labels
Reuters Inhalers, a portable form of nebulizer, turn liquid medication into a fine mist, which is the fastest way for people with asthma or other lung conditions to dose themselves during an attack. But the devices contain pressurized gas along with medication … |
View full post on asthma – Google News
|
Roche biotech drug offers new way to fight asthma
Reuters The encouraging response seen with quilizumab, which the Swiss group is developing as a treatment for moderate-to-severe asthma, underscores the growing focus on novel biotech medicines for hard-to-treat cases of the disease. Other companies working … |
View full post on asthma – Google News
|
BRIEF-Vectura says in US collaboration agreement for VR506 asthma therapy
Reuters Announces a further US collaboration agreement with a leading international pharmaceutical company for VR506 asthma therapy. * Vectura's partner will be responsible for commercialisation and manufacture of product together with clinical development … |
View full post on asthma – Google News
|
US CDC survey shows reported decline in asthma, but experts wary
Thomson Reuters Foundation (blog) NEW YORK, June 19 (Reuters) – Self-reported U.S. asthma rates have fallen significantly for the first time in four years to a nine-year low, according to a survey released on Thursday, but researchers cautioned that the numbers may not mean the disease … |
View full post on asthma – Google News
|
US CDC survey shows reported decline in asthma, but experts wary
Reuters About 7.4 percent of the U.S. population reported having asthma in 2013, down from a level that has hovered around 8.5 percent since 2009, the U.S. Centers for Disease Control and Prevention survey found. That drop represents about 3 million U.S … |
View full post on asthma – Google News
|
UPDATE 1-AstraZeneca builds pipeline with $232 mln Synairgen asthma deal
Reuters LONDON, June 12 (Reuters) – AstraZeneca has struck a deal worth up to $232 million in milestone payments to acquire rights to a drug from Synairgen for treating respiratory tract viral infections in patients with severe asthma. Britain's second-biggest … |
View full post on asthma – Google News
Reuters |
AstraZeneca builds pipeline with $232 million Synairgen asthma deal
Reuters AstraZeneca plans to start a mid-stage Phase IIa study with the drug in early 2015 in patients with severe asthma, building on results from an initial Phase lla trial in a broad asthma population. Severe asthma is a growing focus for major drugmakers … Synairgen shares soar on AstraZeneca asthma deal AstraZeneca licenses rights to Synairgen asthma drug |
View full post on asthma – Google News
|
Exposure to smoke in cars may worsen asthma: study
Reuters The study team cannot prove the smoke exposure caused asthma in the people interviewed, but they warn that smoke can seriously aggravate asthma symptoms and suggest drivers and passengers voluntarily ban smoking in their cars. “It's problematic from … |
View full post on asthma – Google News
|
Two drugs are better than one for asthma control: study
Reuters Based on a review of data from 64 asthma drug trials, the new study found that patients using inhaled corticosteroids with a long-acting bronchodilator had about half as many symptom flare ups and asthma attacks as those just on the steroids. “There … |
View full post on asthma – Google News
|
Good asthma management may stave off kids' anxiety
Reuters “The original literature, mostly from America, suggested that kids with asthma were at risk for anxiety, depression and low self-esteem, but that's not what we've encountered in our clinical practice,” said the lead author of a new study, Professor … |
View full post on asthma – Google News